Dermal fillers

Jawline, Chin and Cheek Filler: What to Know First

How long jawline, chin and cheek filler lasts, what swelling to expect, which areas the FDA warns about, who should wait and what ASPS reports it costs.

AI-generated illustration of a man in his thirties looking out of a window

Short answer

Hyaluronic acid filler in the jawline, chin and cheeks fades over time, and the FDA says duration depends on the filler and the area. In FDA reviews of one filler per area, 61% of jawline and 58% of chin patients still met the response standard 12 months after their last treatment, as did 67% of cheek patients in follow-up at 24 months. Swelling is common. The FDA calls a blocked blood vessel rare but serious.

How long does jawline, chin and cheek filler last?

It depends on the area and the product, and no single number fits everyone. In the FDA's review of one filler per area, 61.3% of jawline patients and 57.6% of chin patients still met the response standard 12 months after their last treatment, as did 67.1% of cheek patients still in follow-up at 24 months. Each trial used its own scale, so the figures are not directly comparable.

Those figures come from the FDA's summaries of three trials: one for a jawline filler approved in 2022, one for a chin filler approved in 2020 and one for a cheek filler approved in 2013. A responder was a patient whose blinded rating improved by at least one grade, among those assessed at that visit. Each trial allowed a touch-up about a month after the first session. The jawline rate fell from 78.7% at 1 month to 61.3% at 12 months, the chin rate was 56.3% at 6 months and 57.6% at 12 months, and the cheek rate fell from 85.6% at 6 months to 67.1% at 24 months. In the cheek trial, patients left follow-up once their score fell back to baseline after month 12, so the 24-month rate probably looks better than it would for everyone treated.

A responder rate is not the whole story. At 6 months, untreated comparison groups also scored as responders in 39.1% of jawline, 27.5% of chin and 38.9% of cheek patients. In the chin trial, blinded evaluators scoring profile images found 56.3% responders, with rates below 50% in adults aged 51.5 and older, darker skin types and men, and a separate blinded rating of 3D images found 43.0%, yet 87.3% of treated patients rated their chin improved or much improved. The FDA says repeated long-term use has not been evaluated in a controlled clinical study. A 2026 systematic review of 11 chin studies called its evidence heterogeneous and largely non-comparative.

AreaWhat it changesStill responders in one FDA trialKey risk to ask about
ChinAdds projection and improves the chin profile57.6% at 12 monthsSwelling and lumps; a blocked vessel is rare but serious
JawlineImproves jawline definition when it has softened61.3% at 12 monthsLumps and firmness; chewing difficulty in 2.0% of one trial
CheeksCorrects age-related midface volume loss67.1% at 24 months (patients still followed)More adverse events with larger amounts and in people over 60

What does filler change in the chin, jawline and cheeks?

Chin filler adds projection to improve the chin profile, jawline filler improves a jaw edge that has softened, and cheek filler corrects the volume the midface loses with age. The FDA approves products for specific areas, so a filler cleared for one area is not automatically cleared for another.

The FDA approved the jawline product for adults over 21 with moderate to severe loss of jawline definition, and the cheek product to correct age-related volume deficit in the midface. The jawline trial randomized 206 adults, averaging 59 years old (range 26 to 81) and 87.4% women, and the manufacturer funded it. The cheek trial enrolled adults aged 35 to 65, and the chin trial's median age was 51.5.

ANEWU's dermal fillers page says fillers address lost volume, not loose skin or descended tissue. For fullness in the lower cheeks rather than hollowness, see our buccal fat removal guide, and for muscle movement, our botulinum toxin versus filler guide.

AI-generated illustration of a clean treatment room with a reclined chair and a tray of gauze

What swelling and bruising should you expect after jaw, chin or cheek filler?

Expect swelling, bruising and tenderness for days, and lumps for longer. In the FDA's summary of one jawline trial, 77.6% of patients recorded swelling and 69.4% bruising in diaries, and for most of them the longest episode lasted a week or less. Lumps lasted longest: 32.7% of all patients recorded them for 15 to 30 days.

The table comes from diaries kept for 30 days by 196 patients after their first treatment. Durations run from the first to the last day a reaction was recorded, and the four duration columns are shares of all 196 patients, not only of those with the reaction. Seven patients (3.6%) rated their worst swelling severe, meaning it compromised daily activities. This is one product in one manufacturer-funded trial.

A 2020 Australasian expert consensus says some lumps or firmness for up to 4 weeks is normal. It advises skipping strenuous activity on the first day and avoiding sleeping face-down or rubbing the face for a week, but labels that advice as not evidence-based. It does not recommend icing, because ice may mask signs of a blocked vessel. The FDA adds that some filler side effects can appear weeks, months or years after injection. Follow your injector's written instructions.

ReactionPatients who recorded itLongest episode 1 to 3 days4 to 7 days8 to 14 days15 to 30 days
Swelling77.6%37.2%23.5%11.7%5.1%
Bruising69.4%24.5%18.9%19.4%6.6%
Lumps or bumps79.1%20.9%12.8%12.8%32.7%

What is the riskiest place for filler, and how risky is jaw filler?

The FDA recommends against injecting filler into the glabella (between the eyebrows), nose, area around the eyes, forehead or neck, and calls filler entering a blood vessel the most concerning risk of any dermal filler. It says the chance is low, but tissue death, blindness and stroke have been reported. No source reviewed gives a dependable risk rate by area, so jaw, chin and cheek filler cannot be ranked as lower or higher risk.

For the jawline, the FDA's summary of its one approved jawline filler trial lists 20 treatment-related adverse events in 16 of 198 patients (8.1%). They included mastication disorder, meaning difficulty chewing, in 4 patients (2.0%) and a lump at the injection site in 3 (1.5%). A report on the same trial found no compromise to vision, jaw function, sensation or pronunciation, but about 200 people cannot show rare events. For the chin, a 2023 systematic review of 24 articles covering 2,259 patients given hyaluronic acid chin filler said one included study reported a major necrotic complication; its abstract gives no overall rate.

The cheeks and chin are not exempt either. The FDA's review of one cheek and chin filler lists vision abnormalities reported after injection into the nose, glabella, periorbital area and/or cheek, though it says events needing medical intervention followed injections in the glabella, nose and periorbital area, outside the approved use. A 2025 meta-analysis pooled only 31 published cases, drawn from case reports and retrospective data. Its authors name the glabella, nose and nasolabial folds as most commonly implicated, yet its table counts the cheek (4 cases) as often as the glabella (4) and lists no chin or jawline cases, so it cannot give a rate for any area. The FDA says to seek immediate medical attention for unusual pain, vision changes, white, gray or blue skin near the injection site, or signs of a stroke.

Is jawline filler a good idea, and who should wait?

It can be a reasonable choice if you want a temporary, non-surgical change and accept repeat visits and a chance of lumps or other effects. Wait if you are pregnant, breastfeeding or under 22, because the FDA says safety is unknown, or if your skin is inflamed or infected or you are unwell. Ask first if dental work is planned. It is a weaker fit if you want a result with no maintenance.

Tell your provider about a bleeding disorder, severe allergies or a history of anaphylaxis, or allergy to lidocaine or to bacteria, since some hyaluronic acid is made by bacterial fermentation. The FDA says safety is unknown in people prone to excessive scarring, and lists dental procedures among events that may cause inflammation near a filler. A 2020 expert consensus lists poor periodontal hygiene, current cold sores and uncontrolled type 2 diabetes among infection risk factors and advises delaying treatment when you are unwell.

The 2026 chin review found over 90% of patients satisfied but could not draw long-term conclusions, and the jawline trial reached its response standard in 69.9% of patients at 6 months, so about 30% did not. Who injects matters too, and our guide to who can legally inject botulinum toxin and fillers explains what to check. Questions to ask your injector:

  • Which product will you use, and is it FDA-approved for this area?
  • What is your training in this area, and what is your plan if a vessel is blocked?
  • How much do you expect to use, and how does the price change?
  • Will I get written aftercare and an after-hours number?
  • How would this fit around planned dental or oral surgery?
  • If I dislike the result, what are my options, and who would do it?

How much does jawline filler cost?

ASPS's 2023 statistics report lists a national average surgeon or physician fee of $715 for hyaluronic acid filler injections, down from $794 in 2022. That is one figure for all hyaluronic acid filler, not a price for the jawline, chin or cheeks, and ASPS does not say how much product it covers. Fees vary by region and patient needs, and your total depends on how much filler is used and how many areas are treated.

ASPS's 2022 fee table adds that fees generally vary according to region and patient needs, are averages only, and exclude anesthesia, operating room facilities and related expenses. ASPS's dermal filler cost page still quotes $715 and says cost varies with the injector's qualifications, the time involved and the office's location. None of these ASPS pages gives a separate figure for those areas, so it cannot tell you what a jawline plan costs. The jawline trial treated several sites at once, so a quote tied to a written plan is more useful than a headline price.

ANEWU's dermal fillers page says cost depends on how many areas are treated and which product each area needs, so it is quoted after a free consultation rather than from a price list. It adds that dental and medical insurance does not typically cover facial aesthetics, and that ANEWU works with CareCredit and Proceed Finance.

Can chin, jawline or cheek filler be dissolved?

Hyaluronic acid filler can be dissolved with an enzyme called hyaluronidase, and it also fades on its own. The FDA warns that fillers not made of materials such as hyaluronic acid can be difficult or impossible to remove. In a 2025 meta-analysis of published blocked-vessel cases, 16 of 19 hyaluronic acid cases (84.2%) recovered partly or fully after hyaluronidase, a very small and selective sample.

Dissolving is a medical treatment with trade-offs. The FDA says reducing or removing a filler can take injections, surgery or other interventions, and these carry their own risks. The meta-analysis drew on case reports and retrospective data, which emphasize severe events, so 84.2% describes reported emergencies, not routine dissolving of an unwanted result. ANEWU's dermal fillers page says hyaluronic acid fillers can be dissolved if a change is needed, but it does not say who performs dissolving, so ask.

Our guide to dermal filler risks and dissolving explains how the enzyme works and what to expect. Before treatment, ask which material will be used and who would dissolve it if you wanted a change.

What does this look like at ANEWU?

ANEWU's site says Dr. Arshia Payman, MD, a board-certified physician specializing in aesthetic medicine, performs every dermal filler treatment, and that candidacy is confirmed at a free consultation in Buckhead, Cumming or Dawsonville. The dermal fillers page lists wanting a non-surgical way to refine cheek or jaw contour among the signs you may be a candidate. There is no pressure to book on the day.

According to the site, the consultation includes a look at your face at rest and in movement and a map of which areas need volume, and Dr. Payman will say when fillers are the wrong tool. She names the product she recommends for each area. Comfort measures such as topical numbing are used where appropriate, and a follow-up visit is available to review and refine the result. The page mentions cheek and jaw contour but not the chin by name, so ask whether it is treated.

Facial aesthetics sits inside an oral and facial surgery practice, and the site says that when a case touches both sides, the plans are made in the same building. To talk it through, you can request a free consultation or call (470) 567-6415.

Sources and further reading

  1. Dermal Fillers (Soft Tissue Fillers) U.S. Food and Drug Administration, content current as of 07/06/2023
  2. JUVEDERM VOLUX XC (jawline definition): Summary of Safety and Effectiveness Data, PMA P110033/S065 U.S. Food and Drug Administration, approved July 29, 2022
  3. JUVEDERM VOLUMA XC (chin augmentation): Summary of Safety and Effectiveness Data, PMA P110033/S047 U.S. Food and Drug Administration, approved June 12, 2020
  4. JUVEDERM VOLUMA XC (cheek augmentation): Summary of Safety and Effectiveness Data, PMA P110033 U.S. Food and Drug Administration, approved October 22, 2013
  5. Hyaluronic Acid Filler VYC-25L for Jawline Restoration Yields High Satisfaction, Improved Jawline Measurements, and Sustained Effectiveness Across Skin Types, Age, and Gender for up to 12 Months Aesthetic Surgery Journal, 2024
  6. Injectable Filler-Based Chin Augmentation: A Systematic Review of Non-Surgical Volumetric Techniques Aesthetic Plastic Surgery, 2026
  7. The Application and Efficacy of Hyaluronic Acid Fillers for Chin Enhancement and Retrusion Correction: A Systematic Review of Patient-Reported Outcomes Cureus, 2023
  8. Risk Factor Analysis for Vascular Occlusions After Dermal Filler Injections: A Systematic Review and Meta-Analysis Cureus, 2025
  9. Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes Australasian Journal of Dermatology, 2020
  10. 2023 Plastic Surgery Statistics Report (Procedural Statistics Release, including average surgeon and physician fees) American Society of Plastic Surgeons, 2023 (archived copy)
  11. 2022 Average Surgeon/Physician Fees (archived copy) American Society of Plastic Surgeons, 2022 data, Internet Archive copy
  12. Dermal Fillers Cost American Society of Plastic Surgeons, web page (undated), accessed October 2026

This article is general information about dental and facial procedures, not a diagnosis or medical advice. Every jaw and every health history is different, so the right plan for you can only be set after an exam and imaging with a surgeon.

Where can I be seen?

ANEWU has three Georgia offices, in Buckhead, Cumming and Dawsonville. Which office offers a given treatment, and on which days, is easiest to confirm when you book.

Common questions

No head-to-head ranking of brands for the chin was identified for this article. The FDA says it approved different products for use in specific areas of the face, so a useful question is whether your product is approved for the area. The FDA trial summaries used here each compared one product with no treatment, not with another filler.

No source identified for this article defines a normal number of syringes for cheeks, so this article gives none. In the FDA's 2013 cheek review, adverse events were seen more often in people given larger amounts and in people over 60. Ask your injector how the amount was chosen for your face.

It was uncommon but reported. In the FDA's summary of one jawline filler trial, treating investigators judged mastication disorder, meaning difficulty chewing, to be treatment-related in 4 of 198 patients (2.0%) and temporomandibular joint syndrome in 1 (0.5%). The summary says the chewing problems all resolved within 3 days. Tell your injector about jaw pain or clenching before treatment, since a trial this size cannot show who is at risk.

No source identified for this article gives a recommended interval. The FDA says inflammation near a filler may develop after viral or bacterial illnesses, vaccinations or dental procedures, and a 2020 expert consensus lists poor periodontal hygiene as an infection risk factor. Tell your dentist about recent filler, tell your injector about planned dental work, and ask both for written advice on timing.

The FDA says safety is unknown during pregnancy, while breastfeeding and in patients under 22, and the approvals cited here are for adults over 21. A 2020 Australasian expert consensus says to defer treatment in pregnancy and breastfeeding. Ask your provider about their policy.

Not on day one. The 2020 expert consensus suggests patients treated in a new area return about 2 to 4 weeks later to evaluate the outcome, when a touch-up can be done. In the FDA jawline trial, an optional touch-up was offered at about 1 month. ANEWU's dermal fillers page says a follow-up visit is available to review and refine the result.

Call nowFree consultation